Literature DB >> 9299454

Carboxyl terminus of delta opioid receptor is required for agonist-dependent receptor phosphorylation.

J Zhao1, G Pei, Y L Huang, F M Zhong, L Ma.   

Abstract

The wild-type delta opioid receptor (DOR) and a carboxyl terminus-truncated mutant DOR lacking the last 31 amino acids (DOR-T) were expressed in neuroblastoma x glioma hybrid NG108-15 cells to investigate the role of the carboxyl terminus of DOR in agonist-dependent receptor phosphorylation. Stimulation of the cells with delta specific agonists significantly induced DOR phosphorylation whereas no phosphorylation of DOR-T was detected under the same conditions. Neither overexpression of G protein-coupled receptor kinases (GRK2 or GRK5) nor activation of protein kinase C promoted agonist-induced phosphorylation of DOR-T, in contrast to their strong stimulatory effect on the agonist-dependent phosphorylation of DOR. Furthermore, DOR-T failed to be internalized after agonist stimulation, probably due to its inability to be phosphorylated. Our results indicate that the carboxyl terminus of DOR is required for agonist-dependent receptor phosphorylation and the phosphorylation site(s) of DOR is likely located at its carboxyl terminus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299454     DOI: 10.1006/bbrc.1997.7242

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Hierarchical phosphorylation of delta-opioid receptor regulates agonist-induced receptor desensitization and internalization.

Authors:  O M Kouhen; G Wang; J Solberg; L J Erickson; P Y Law; H H Loh
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 2.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

Review 3.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

4.  Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids.

Authors:  W Xie; G M Samoriski; J P McLaughlin; V A Romoser; A Smrcka; P M Hinkle; J M Bidlack; R A Gross; H Jiang; D Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

5.  G-protein-coupled receptor kinase 5 phosphorylates p53 and inhibits DNA damage-induced apoptosis.

Authors:  Xiaoqing Chen; Huiling Zhu; Man Yuan; Jie Fu; Yuqing Zhou; Lan Ma
Journal:  J Biol Chem       Date:  2010-02-02       Impact factor: 5.157

6.  G protein independent phosphorylation and internalization of the delta-opioid receptor.

Authors:  Faye A Bradbury; Jennifer C Zelnik; John R Traynor
Journal:  J Neurochem       Date:  2009-04-01       Impact factor: 5.372

Review 7.  Protein kinase C in pain: involvement of multiple isoforms.

Authors:  Kandy T Velázquez; Husam Mohammad; Sarah M Sweitzer
Journal:  Pharmacol Res       Date:  2007-04-29       Impact factor: 7.658

8.  Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors.

Authors:  J Zhao; L H Ben; Y L Wu; W Hu; K Ling; S M Xin; H L Nie; L Ma; G Pei
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

9.  Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies.

Authors:  Anika Mann; Sophia Liebetrau; Marie Klima; Pooja Dasgupta; Dominique Massotte; Stefan Schulz
Journal:  Sci Rep       Date:  2020-05-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.